Tonix Pharm Hldg (TNXP) Posts Q1 Loss of 59c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Go back to Tonix Pharm Hldg (TNXP) Posts Q1 Loss of 59c/Share

Enrollment in Tonix (TNXP) BESTFIT Trial Completed

May 12, 2014 8:41 AM EDT

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) announced that it has completed enrollment in the BESTFIT trial of TNX-102 SL for fibromyalgia, after having achieved the randomization goal of 200 subjects.

BESTFIT (BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy) is a 12-week, randomized, double-blind, placebo-controlled trial of TNX-102 SL (cyclobenzaprine... More